Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

The Lancet

Volumn 388, Issue 10047, 2016, Pages 881-890

  Cipriani, Andrea ^a   Zhou, Xinyu ^b,c   Del Giovane, Cinzia ^d   Hetrick, Sarah E ^e   Qin, Bin ^b,c   Whittington, Craig ^f   Coghill, David ^g,h   Zhang, Yuqing ^b,c   Hazell, Philip ⁱ   Leucht, Stefan ^j   Cuijpers, Pim ^k   Pu, Juncai ^b,c   Cohen, David ^l   Ravindran, Arun V ^m,n   Liu, Yiyun ^b,c   Michael, Kurt D ^o   Yang, Lining ^b,c   Liu, Lanxiang ^b,c   Xie, Peng ^b,c,p  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Doctor Evidence LLC   (United States)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k VU UNIVERSITY AMSTERDAM   (Netherlands)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^o APPALACHIAN STATE UNIVERSITY   (United States)

^p SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE; MIANSERIN; TRIAZOLE DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CINAHL; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMBASE; HUMAN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; WEB OF SCIENCE; ANALOGS AND DERIVATIVES; BAYES THEOREM; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; METHODOLOGY; TREATMENT OUTCOME;

ADOLESCENT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; BAYES THEOREM; CHILD; CITALOPRAM; CLOMIPRAMINE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEPRESSIVE DISORDER, MAJOR; DESIPRAMINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DULOXETINE HYDROCHLORIDE; EVIDENCE-BASED MEDICINE; FLUOXETINE; HUMANS; IMIPRAMINE; MIANSERIN; NORTRIPTYLINE; PAROXETINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SERTRALINE; TREATMENT OUTCOME; TRIAZOLES; VENLAFAXINE HYDROCHLORIDE;

EID: 84988473938     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30385-3     Document Type: Article

References (30)

1. 1 Costello, JE, Erkanli, A, Angold, A, Is there an epidemic of child or adolescent depression?. J Child Psychol Psychiatry 47 (2006), 1263–1271.
2. 2 Olfson, M, Blanco, C, Wang, S, Laje, G, Correll, CU, National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry 71 (2014), 81–90.
3. 3 Thapar, A, Collishaw, S, Pine, DS, Thapar, AK, Depression in adolescence. Lancet 379 (2012), 1056–1067.
4. 4 Hopkins, K, Crosland, P, Elliott, N, Bewley, S, for the Clinical Guidelines Update Committee B. Diagnosis and management of depression in children and young people: summary of updated NICE guidance. BMJ, 350, 2015, h824.
5. 5 Malhi, GS, Bassett, D, Boyce, P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 49 (2015), 1087–1206.
6. 6 Bachmann, CJ, Aagaard, L, Burcu, M, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012. Eur Neuropsychopharmacol 26 (2016), 411–419.
7. 7 US Food and Drug Administration. Suicidality in children and adolescents being treated with antidepressant medications. www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm155488.htm, Oct 15, 2004 (accessed Oct 18, 2015).
8. 8 Hetrick, SE, McKenzie, JE, Cox, GR, Simmons, MB, Merry, SN, Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev, 11, 2012 CD004851.
9. 9 Whittington, CJ, Kendall, T, Fonagy, P, Cottrell, D, Cotgrove, A, Boddington, E, Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363 (2004), 1341–1345.
10. 10 Tsapakis, EM, Soldani, F, Tondo, L, Baldessarini, RJ, Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 193 (2008), 10–17.
11. 11 Zhou, X, Qin, B, Whittington, C, et al. Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis. BMJ Open, 5, 2015, e007768.
12. 12 Hammad, TA, Relationship between psychotropic drugs and pediatric suicidality. http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf, 16 August 2004 (accessed May 12, 2016).
13. 13 The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions (Version 5.1.0). http://handbook.cochrane.org, March, 2011 (accessed Oct 20, 2015).
14. 14 Cipriani, A, Furukawa, TA, Salanti, G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373 (2009), 746–758.
15. 15 Salanti, G, Higgins, JP, Ades, AE, Ioannidis, JP, Evaluation of networks of randomized trials. Stat Methods Med Res 17 (2008), 279–301.
16. 16 Brooks, SP, Gelman, A, General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7 (1998), 434–455.
17. 17 Neupane, B, Richer, D, Bonner, AJ, Kibret, T, Beyene, J, Network meta-analysis using R: a review of currently available automated packages. PLoS One, 9, 2014, e115065.
18. 18 Chaimani, A, Higgins, JP, Mavridis, D, Spyridonos, P, Salanti, G, Graphical tools for network meta-analysis in STATA. PLoS One, 8, 2013, e76654.
19. 19 Dias, S, Welton, NJ, Caldwell, DM, Ades, AE, Checking consistency in mixed treatment comparison meta-analysis. Stat Med 29 (2010), 932–944.
20. 20 Salanti, G, Ades, AE, Ioannidis, JP, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64 (2011), 163–171.
21. 21 Salanti, G, Del Giovane, C, Chaimani, A, Caldwell, DM, Higgins, JP, Evaluating the quality of evidence from a network meta-analysis. PLoS One, 9, 2014, e99682.
22. 22 Cohen, J, Statistical power analysis for the behavioral sciences, 2nd edn., 1988, Lawrence Erlbaum Associates, Hillsdale, NJ.
23. 23 Biau, DJ, Kernéis, S, Porcher, R, Statistics in brief: the importance of sample size in the planning and interpretation of medical research. Clin Orthop Relat Res 466 (2008), 2282–2288.
24. 24 Le Noury, J, Nardo, JM, Healy, D, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ, 351, 2015, h4320.
25. 25 Brunoni, AR, Tadini, L, Fregni, F, Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology. PLoS One, 5, 2010, e9479.
26. 26 Samara, MT, Dold, M, Gianatsi, M, et al. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry 73 (2016), 199–210.
27. 27 Cipriani, A, Higgins, JP, Geddes, JR, Salanti, G, Conceptual and technical challenges in network meta-analysis. Ann Intern Med 159 (2013), 130–137.
28. 28 Emslie, GJ, Heiligenstein, JH, Hoog, SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 43 (2004), 1397–1405.
29. 29 Zhou, X, Hetrick, SE, Cuijpers, P, et al. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: a systematic review and network meta-analysis. World Psychiatry 14 (2015), 207–222.
30. 30 Kakuma, R, Minas, H, van Ginneken, N, et al. Human resources for mental health care: current situation and strategies for action. Lancet 378 (2011), 1654–1663.